ArticleEuropean radiology2026
MRI scoring of pleural findings in cystic fibrosis does not require intravenous contrast media.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesCystic fibrosis (CF) leads to severe lung disease requiring regular monitoring. The morpho-functional chest MRI score enables reproducible semi-quantitative assessment of CF-related pulmonary and pleural changes, but the optimal sequences for pleural evaluation and the need for intravenous contrast media remain uncertain. This study aims to investigate the usability and agreement of different unenhanced and contrast-enhanced MRI sequences in assessing CF-related pleural findings using a blinded multi-reader study design. MATERIALS AND
methodsThis study included 75 people with CF (pwCF), who underwent morpho-functional chest MRI comprising contrast-enhanced and unenhanced sequences. Three 3D gradient echo T1-weighted sequences (unenhanced with (T1UEFS) and without fat saturation (T1UE), contrast-enhanced with fat saturation (T1CEFS)) and a high-resolution T2-weighted sequence with fat saturation (T2FS) were evaluated by two blinded independent readers applying the chest MRI scoring system for each individual lung lobe and the entire pleura (lobar/total pleural findings score). In case of deviations, a thoracic radiologist adjudicated. Statistical analyses included Spearman's correlation, Kruskal-Wallis test, and intraclass correlation coefficients.
resultsInterreader agreement was consistently good for all sequences and for all pulmonary lobes. While all unenhanced MRI sequences showed strong correlation with T1CEFS regarding the total pleural findings score, T1UEFS showed the highest agreement. T2FS tended to overestimate, and T1UE tended to underestimate lobar and total pleural findings scores.
conclusionsContrast-enhanced T1-weighted imaging is standard for assessing CF-related pleural inflammation and thickening. Our findings show that contrast agent-free fat-saturated T1-weighted sequences provide equivalent diagnostic value, indicating contrast media are not required for pleural assessment in pwCF. KEY POINTS: Question It is unclear which MRI sequence is best for assessing signs of pleurisy in pwCF and whether intravenous contrast media is required. Findings Pleural inflammation and thickening can be diagnosed just as precisely with an unenhanced fat-saturated T1-weighted sequence as with a contrast-enhanced T1-weighted sequence. Clinical relevance The assessment of pleural findings in MRI is not dependent on the use of intravenous contrast media. For pwCF, this paves the way for future routine MRI monitoring without contrast agents, thereby streamlining imaging protocols and reducing patient burden.
Indexed as
Identifiers
41436642What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.